Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)

计划入组 48 人 · 首次发布于 2025 年 7 月 30 日

Intravesical BCG Administration to Patients With Invasive Bladder Cancer

计划入组 6 人 · 首次发布于 2015 年 2 月 18 日

A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

计划入组 24 人 · 首次发布于 2017 年 7 月 11 日

Mycobacterium bovis BCG live attenuated vaccine (Bandim Health Project)

rBCG-FGFR3MUT

Mycobacterium bovis BCG (Bacillus Calmette-Guerin)(Aj Vaccines A/S)

DE BONIS MICHELE

Italy

Covis Pharma GmbH

Switzerland

NOVIS PR LLC

United States

MTBVAC TB Vaccine Enters Landmark Phase 2b Trial Across Three African Countries

Century-Old BCG Tuberculosis Vaccine Shows Promise in Reducing Insulin Use in Type 1 and LADA Diabetes

Breakthrough Tuberculosis Drug Targets and Novel Therapeutic Strategies Show Promise Against Drug-Resistant Strains